Amneal Pharmaceuticals, Inc. SEC filings AMRX
Amneal Pharmaceuticals, Inc. has 694 filings in SEC EDGAR's recent list, going back to Nov 21, 2017. Its latest annual report, Form 10-K, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Sep 3, 2026 | — |
| S-8 POS | Filing | Nov 8, 2023 | — |
| S-8 POS | Filing | Nov 8, 2023 | — |
| S-8 POS | Filing | Nov 8, 2023 | — |
| POS AM | Filing | Nov 8, 2023 | — |
| POS AM | Filing | Nov 8, 2023 | — |
| S-8 | Employee stock plan registration | Aug 9, 2023 | — |
| POS AM | Filing | Mar 6, 2023 | — |
| POS AM | Filing | Mar 6, 2023 | — |
| S-3ASR | Automatic shelf registration | Mar 2, 2022 | — |
| S-3ASR | Automatic shelf registration | Mar 2, 2022 | — |
| S-8 | Employee stock plan registration | Aug 17, 2020 | — |
| S-3ASR | Automatic shelf registration | Mar 1, 2019 | — |
| 424B3 | Prospectus | Nov 13, 2018 | — |
| 424B7 | Prospectus supplement no. 5 | Sep 7, 2018 | — |
| 424B3 | Prospectus | Aug 13, 2018 | — |
| 424B3 | Prospectus | Jul 12, 2018 | — |
| 424B3 | Prospectus | Jun 7, 2018 | — |
| 424B3 | Prospectus | May 11, 2018 | — |
| 424B3 | Prospectus | May 10, 2018 | — |
| S-1/A | Amended registration statement | May 9, 2018 | — |
| S-1 | Registration statement | May 7, 2018 | — |
| S-8 | Employee stock plan registration | May 7, 2018 | — |
| S-1/A | Amended registration statement | Apr 13, 2018 | — |
| S-1 | Registration statement | Mar 7, 2018 | — |
| 424B3 | Prospectus | Feb 12, 2018 | — |
| S-4/A | Amendment no. 4 to form s-4 | Feb 6, 2018 | — |
| S-4/A | Amendment no. 3 to form s-4 | Feb 1, 2018 | — |
| S-4/A | Amendment no. 2 to form s-4 | Jan 23, 2018 | — |
| S-4/A | Amendment no. 1 to form s-4 | Dec 29, 2017 | — |
| S-4 | Registration for a merger or exchange | Nov 21, 2017 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AMRX (Nasdaq)
- Fiscal year ends
- December 31
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1723128
- Former names
- Atlas Holdings, Inc. (until Apr 13, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.